Funding This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors
Large meals overwhelm a stomach that is emptying more slowly due to GLP-1 activation
Other animal studies have found that GLP-1R agonists reduce amphetamine use and amphetamine-induced hyperlocomotion
Its most-studied use is in combination: co-administered with semaglutide (CagriSema), weight loss reached 15.6% at 32 weeks far beyond semaglutide alone (5.1%)[2]
If you experience excessive drowsiness, muscle weakness, or irregular heartbeat, reduce your dosage and consult with a healthcare provider
No longer confined to pro athletes or experimental clinics, peptide-based medicine is entering the mainstream and Diamond Health is proud to be on the forefront of this transformation